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Abstract 
The study was performed using surgical and biopsy material based on histopathological study, which was con-
ducted at the Chernivtsy Regional Clinical Oncology Centre. In the cases of verified diagnosis of ductal breast carci-
noma was studied the size of the primary tumour node and metastasis in lymphogenous features of regional lymph 
node according to classification system TNM. All cases were divided by categories T and N. Using statistical data was 
conducted the analysis in patients of verified diagnosis of ductal breast carcinoma in Chernivtsy region. We determined 
the features of metastasis to regional lymph nodes under according to the classification pTNM and confidence intervals 
calculated according to percent binomial method with p=0.05. After receiving the results the data were compared to 
predict metastasis. Using statistical data were conducted the analysis in women of Chernivtsi region with verified diag-
nosis of ductal breast cancer. We determined the features of metastasis classification according pTNM and confidence 
intervals of percent according to binominal method with p=0.05. All observations of histopathological conclusions were 
conducted on the basis of Chernivtsy Regional Clinical Oncology Centre. 
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1. Introduction
Breast carcinoma ranks first in the world like a malignant cancer in women (Fig. 1).
Fig. 1. Invasive ductal breast cancer
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Malignancy of the disease is caused by the emergence of metastases. Metastases – secondary 
tumour focus in tissues arising from the spread of the tumour in the patient’s body (Fig. 2, 3).
Fig. 2. Metastasis breast cancer in an axillary lymph nodes
Fig. 3. Metastasis breast cancer in an axillary lymph nodes
The problem of the emergence of metastases more significant than the primary tumour [1, 2]. 
If the primary tumour can be treated surgically, it is  much more difficult, and often impossible to 
identify and remove multiple metastases [2–4]. The presence of metastases immediately worsens 
the prognosis of life and treatment of tumours. An important task is to prevent metastasis and to 
detect cancer at an early stage. This kind of research are essential because the occurrence of sec-
ondary tumours in the later stages of the disease are the leading causes of death in sick women [5]. 
Many scientists study the possibility of appearance metastasis for a long time. Research methods 
of forecasting the emergence of metastases are interesting because in solving problem are arising 
chances to prevent undesirable complications of tumour [5, 6].
One of the priority tasks of predicting ductal breast carcinoma metastasis is the use of meth-
ods that are based on an assessment of the primary node size (based on system TNM). In partic-
ular, one could calculate the overall rate at a certain contingent of women, incidence of certain 
types of metastases and to evaluate the prognosis of their frequency by using one of the existing 
statistical methods [7–10]. Today, the best method of frequency prediction is calculating binominal 
confidence intervals percent. This method uses a complex mathematical algorithm, but it is the 
most mathematically justified among other methods-analogues (for instance, “interval Wilson’s” 
or “interval Argesti-Coull»), and therefore is also called “Exact method” and allows you calculate 
confidence intervals taking into account the frequency of asymmetric features, especially when 
analyzed small or great frequency. It should be noted that due to the asymmetrical frequency char-
acteristics it would be wrong to use the previously popular method of calculation of confidence 
intervals by applying a symmetric frequency error [10–12]. So, to predict the frequency of ductal 
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breast cancer metastasis by the tumour size according to the TNM system is used binominal meth-
od of calculating percent confidence intervals (frequencies). 
2. Aim of the research 
To predict metastasis of invasive ductal breast carcinoma by the tumour size (using TNM 
system) in women of Chernivtsi region by using the binominal method for determining percent 
confidence intervals (frequency).
3. Research materials and methods
Study sample included 162 cases of invasive ductal breast carcinoma. Research was con-
ducted in the age group of 27 to 75 years. The average age was 59 years. It was diagnosed on the 
basis of Chernivtsi Regional Clinical Oncology Center in 2014–2015. Additional researches were 
conducted at the Department of Pathology Anatomy of Higher State Educational Establishment of 
Ukraine «Bukovinian State Medical University».
Operational and biopsy material was sent to research to the department of pathologists, 
fixed in buffered phosphate buffer formalin. On the next day was selected material that is most 
suitable for further research: interested tumour tissue on both sides of the border of dense tumour 
site [13]. After fixation and dehydration in ascending alcohol batteries specimens were stained with 
hematoxylin-eosin. According to histopathological techniques were performed micropreparations 
microscopy, was established histopathological diagnosis and coding according to the international 
classification of TNM [13–16]. The required results were analyzed by statistical methods. Retro-
spective analysis and grouping of the results of the study was conducted. All results are divided by 
categories according to classification TNM. Conducted calculation and comparison of the results 
for different variations, calculated percent confidence interval in accordance to binominal method 
with p=0.05. All calculated results are analyzed and criteria for predicting within a confidence 
interval were established.
Using computer software equipment for statistical calculations – PAST 3.11 (O. Hammer, 2016, 
freeware), according to the binominal method were counted the limits for percent confidence interval 
at p=0.05 [17–19].
4. Research results
Study sample included 162 cases of invasive ductal breast carcinoma. It was diagnosed on 
the basis of Chernivtsi Regional Clinical Oncology Center in 2014–2015. Additional researches 
were conducted at the Department of Pathology Anatomy of Higher State Educational Establish-
ment of Ukraine «Bukovinian State Medical University».
To predict metastasis of invasive ductal breast carcinoma in women of Chernivtsi region 
were used categories of classification pTNM with existing cases of verified diagnosis of in-
vasive ductal breast carcinoma. The results were divided on morphological characteristics. In 
the basis of this classification laid morphological characteristics including size of the primary 
tumour and spread T1 – T4c. We paid attention to the size of the primary tumour and metastasis 
features N0-3 (Table 1).
Categories without any disease observation were not shown in the Table 1. In determining 
the confidence interval in these groups the result was identical, that’s why for the prediction it was 
used only as a guide. To the test categories, which did not detect any disease observation, belong 
(T1aN0, T1aN1, T1aN2, T1aN3, T1bN2, T1bN3, T3N2, T4aN0, T4aN1, T4aN1a, T4aN2, T4aN3, T4cN1, T4cN2, T4cN3), 
thus percentage was 0 %, and CL = 0–2,25 %.
In groups with verified diagnosis of ductal breast carcinoma grouped by pTNM to reduce 
subvariations by subcategories N1-3 (a-c) restricted N1-3 to simplify the calculation of results and in-
crease visibility of research.
In observation of categories M (hematogenous metastases) was not get a single case, thus 
all conclusions we studied encrypted as Mx. At this stage of research any information about this 
category was not used.
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Table 1
Analysis of occurrence of ductal breast carcinoma metastasis in percentage and calculation 
limits of the confidence interval for the total number of cases in accordance with binominal 
method at p=0,05
Groups N0 Altogether N1+ N2+ N3 N1 N2 N3
Т
1b
3 (1,85 %)
CL=0,38–5,32 %
1 (0,62 %)
CL=0,15–3,39 %
1 (0,62 %)
CL=0,15–3,39 %
0 %
CL=0–2,25 %
0 %
CL=0–2,25 %
Т
1с
8 (4,93 %)
CL=2,16–9,49 %
16 (9,88) %
CL=5,75–15,54 %
10 (6,17 %)
CL=3,00–11,06 %
2 (1,23 %)
CL=0,15–4,39 %
4 (2,64 %)
CL=0,68–6,20 %
Т2
49 (30,25 %)
CL=23,29–37,95 %
67 (41,36 %)
CL=33,69–49,35 %
29 (17,90 %)
CL=12,33–24,69 %
15 (9,26 %)
CL=5,28–14,81 %
23 (14,20 %)
CL=9,22–20,54 %
Т3
2 (1,23 %)
CL=0,15–4,39 %
2 (1,23 %)
CL=0,15–4,39 %
1 (0,62 %)
CL=0,15–3,39 %
0 %
CL=0–2,25 %
1 (0,62 %4 )
CL=0,15–3,39 %
Т
4b
2 (1,23 %)
CL=0,15–4,39 %
11 (6,79 %)
CL=3,44–11,82 %
6 (3,70 %)
CL=1,37–7,88 %
1 (0,62 %)
CL=0,15–3,39 %
4 (2,46 %)
CL=0,68–6,20 %
Т
4с
1 0,62 %
CL=0,15–3,39 %
0 %
CL=0–2,25 %
0 %
CL=0–2,25 %
0 %
CL=0–2,25 %
0 %
CL=0–2,25 %
Altogether 
(regardless 
of tumour 
size)
65 (40,12 %)
CL=32,51–48,10 %
97 (59,88 %)
CL= 51,90–67,49 %
47 (29,01 %)
CL=22,16–36,65 %
18 (11,11 %)
CL=6,72–16,99 %
32 (19,75 %)
CL=13,92–26,73 %
5. Discussion of the research results
All data are summarized in Table 1. There were no cases with T1a and because of this groups 
and their combination without a confirmed diagnosis it is not necessary to cover in the table, thus a 
result of determining the confidence interval will be identical for all.
In the first column of the table is the group T
1b
 – total number of cases was 4 persons (2.46 %). 
Category N0 – 3 cases of the disease (1.85 %), the confidence interval for this group CL=0,38–5,32 %. 
Category N1a – 1 case (0.62 %), CL=0,15–3,39 %. N2, N3 categories were not observed – 0 %, lim-
its the likely occurrence of metastases within CL=0–2,25 %. Totally N1+N2+N3 – 1 case (0,62 %), 
CL=0,15–3,39 %.
The number of cases in combination with the category T1cN was 24 (14.81%) totally, includ-
ing N0 – 8 observations (4,93 %) CL=2,16–9,49 %; N1 – 10 observations (6,17 %), CL=3,00–11,06 %; 
N2 – 2 observations  (1,23 %), CL=0,15–4,39 %; N3 – 4 observations (2,64 %), CL=0,68–6,20 %. 
Totally N1+N2+N3 – 16 cases.
Group of T2 category is the most numerous, total number of observations is 116 (71.61 %). Con-
fidence interval CL=64,00–78,40 %. The group N0 got 49 observations (30,25 %), CL = 23,29–37,95 %; 
N1 category – 29 observations (17,90 %), CL=12,33–24,69 %; N2 category – 15 observations (9.26 %) 
totally, within the confidence interval 5,28–14,81 %; N3 – 23 observations (14,20 %), CL=9,22–20,54 %. 
Totally N1+N2+N3 – 67 observations (41.4 %).
In combination of categories T3N – 4 observations (2.46 % ) totally, CL=0,68–6,20 %; 
N0 category – 2 observations (1.23 %), confidence interval CL within 0,15–4,39 %. N1 category – 
1 observation (0,62 %), CL=0,15–3,39 %; N2 – there was no single case (0 %), CL=0–2,25 %; N3 – 
1 observation (0,62 %), CL=0,15–3,39 %. Totally N1+N2+N3 – 2 observations (1,23 %), CL=0,15–4,39 %.
The combination of categories T
4b
N consists of 13observations (8,03 %), CL=4,34–10,33 %. 
Category N0 – 2 cases (1,23 %), CL=0,15–4,39 %; N1 – 6 observations (3,70 %), CL=1,37–7,88 %; 
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N2 – 1 observation (0,62 %), CL=0,15–3,39 %; N3 – 4 observations (2,46 %), CL=0,68–6,20 %. 
Totally N1+N2+N3 – 11 observations (8,02 %), CL=3,44–11,82 %.
In combination of categories T4cN – 1 observation which is 0,62 % in the subcategory T4cN0, 
confidence interval CL = 0,15–3,39 %. In categories N1, N2, N3 not a single observation was ob-
served (0 %), CL=0–2,25 %.
Among the 162 observations included in the research group there were 65 cases of no metas-
tasis, which is 40,12 %. The group with metastasis carried 97 observations (59,88 %). In total, the 
number of cases in the N1 category is 47 (29.01 %); N2 – 18 observations (11,11 %); N3 – 32 (19,75 %).
Prediction of the tumour metastasis using binominal method for the purpose of determina-
tion of confidence intervals is rather valuable and reliable. In categories that did not get any obser-
vation (in the ratio of 0 %) using this method was found that the risk of metastasis varies from 0 to 
2.25 %. This makes it possible to use these results as a prognostic significance. Other techniques 
didn’t show such results in groups with missing observations. By the number of cases and the 
emergence of metastases over 71 % of women in category T2 are at high risk for tumour metastasis.
This method allows calculate confidence intervals based on the features asymmetric fre-
quency, especially when analyzed small or great frequency. This statistical method can be used in 
combination with further histopathological studies or evaluation.
6. Conclusions
1. After comparison of results in categories and statistical processing was revealed that a 
group of undetected metastasis by binominal method of calculation of confidence intervals risk of 
metastases ranges from 0 to 2.25 %. In our study, these groups are with combination of categories: 
T1aN0, T1aN1, T1aN2, T1aN3, T1bN2, T1bN3, T3N2, T4aN0, T4aN1, T4aN1a, T4aN2, T4aN3, T4cN1, T4cN2, T4cN3.
2. Using counting limits of confidence intervals for the total number of cases in categories 
of classification pTNM indicates the probability of appearance of disease complications in the form 
of metastases. And, certainly, can be used for predicting metastasis of ductal breast carcinoma.
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